UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Truist Financial Corp

Truist Financial Corp trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 11.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 641,298 shares of the healthcare conglomerate’s stock after selling 86,525 shares during the period. Truist Financial Corp’s holdings in UnitedHealth Group were worth $337,624,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of UNH. Wellington Management Group LLP grew its holdings in UnitedHealth Group by 2.1% in the 3rd quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock valued at $12,715,790,000 after buying an additional 527,526 shares during the period. Northern Trust Corp raised its stake in UnitedHealth Group by 3.6% during the third quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock worth $4,934,895,000 after purchasing an additional 341,749 shares during the period. Bank of New York Mellon Corp grew its stake in shares of UnitedHealth Group by 2.2% during the 3rd quarter. Bank of New York Mellon Corp now owns 8,242,282 shares of the healthcare conglomerate’s stock valued at $4,155,676,000 after buying an additional 180,331 shares during the period. Charles Schwab Investment Management Inc. raised its position in shares of UnitedHealth Group by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock worth $2,937,976,000 after buying an additional 27,127 shares during the period. Finally, Sanders Capital LLC grew its position in UnitedHealth Group by 6.5% during the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock valued at $2,902,829,000 after acquiring an additional 352,710 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on UNH. Bank of America reiterated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a report on Thursday, March 7th. Piper Sandler raised their target price on shares of UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research report on Friday, April 19th. Finally, Wells Fargo & Company reduced their price target on UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. Four investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Stock Up 0.3 %

NYSE UNH traded up $1.49 on Friday, hitting $495.35. 2,608,554 shares of the stock traded hands, compared to its average volume of 4,508,195. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. The company has a market capitalization of $455.76 billion, a P/E ratio of 30.28, a price-to-earnings-growth ratio of 1.41 and a beta of 0.54. The stock has a 50-day moving average of $485.84 and a 200 day moving average of $514.21.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The firm had revenue of $99.80 billion during the quarter, compared to analyst estimates of $99.23 billion. During the same quarter in the previous year, the firm earned $6.26 earnings per share. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is 45.97%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.